FDA Approved: BUPROPION HYDROCHLORIDE (SR) — Supplemental Application (Cipla USA Inc.,)

View source ↗

Summary

The FDA approved Cipla USA Inc.'s supplemental application for Bupropion hydrochloride sustained-release, enabling the generic product to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Seasonal Affective Disorder
• Tobacco Use Disorder

Drugs mentioned

• Bupropion hydrochloride SR (Bupropion hydrochloride)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE (SR) (BUPROPION HYDROCHLORIDE)